Bryan Ball's Insider Trades & SAST Disclosures
Bryan Ball's most recent trade in Whitehawk Therapeutics Inc. was a trade of 100,000 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on March 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Bryan Ball.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Whitehawk Therapeutics Inc.
|
Bryan Ball | See remarks | Grant, award, or other acquisition of securities at price $ 2.40 per share. | 01 Mar 2025 | 100,000 | 202,853 | - | 2.4 | 240,000 | Common Stock |
|
Whitehawk Therapeutics Inc.
|
Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,000 | 105,000 | - | - | Common Stock | |
|
Whitehawk Therapeutics Inc.
|
Bryan Ball | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 5,000 | 15,000 | - | - | Restricted Stock Units | |
|
Whitehawk Therapeutics Inc.
|
Bryan Ball | See remarks | Sale of securities on an exchange or to another person at price $ 2.35 per share. | 01 Mar 2025 | 2,147 | 102,853 | - | 2.3 | 5,045 | Common Stock |
|
Intercept Pharmaceuticals Inc
|
Bryan Ball | Chief Qual. Officer & SVP Ops. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.57 per share. | 11 Jul 2022 | 436 | 25,178 (0%) | 0% | 14.6 | 6,353 | Common Stock |
|
Intercept Pharmaceuticals Inc
|
Bryan Ball | Chief Qual. Officer & SVP Ops. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.19 per share. | 11 Apr 2022 | 531 | 25,614 (0%) | 0% | 17.2 | 9,128 | Common Stock |
|
Intercept Pharmaceuticals Inc
|
Bryan Ball | Chief Qual. Officer & SVP Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 6,100 | 6,100 | - | - | Option to Purchase Common Stock | |
|
Intercept Pharmaceuticals Inc
|
Bryan Ball | Chief Qual. Officer & SVP Ops. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 3,600 | 26,145 (0%) | 0% | 0 | Common Stock | |
|
Intercept Pharmaceuticals Inc
|
Bryan Ball | Chief Qual. Officer & SVP Ops. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.83 per share. | 11 Jan 2022 | 2,455 | 22,545 (0%) | 0% | 16.8 | 41,318 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges